Results 201 to 210 of about 5,019,362 (329)

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu   +14 more
wiley   +1 more source

Regional variation in out-of-hospital cardiac arrest incidence and outcome.

open access: yesJournal of the American Medical Association (JAMA), 2008
G. Nichol   +12 more
semanticscholar   +1 more source

Cancer pattern in Bhutan (2014–2022): Findings from population‐based cancer registry—A pathway to monitor cancer control activities

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The establishment in 2014 of the population‐based cancer registry (PBCR) of Bhutan created new opportunities for understanding national cancer trends, which previously were anticipated from data in neighbouring countries. This study presents the first nine‐year summary of cancer patterns in Bhutan, derived from PBCR data. From 2014 to 2022,
Phub Tshering   +9 more
wiley   +1 more source

Patient‐ and caregiver‐reported barriers to chemotherapy in nine sub‐Saharan African countries: A cross‐sectional survey among population‐based registries

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Increasing cancer incidence and mortality in low‐ and middle‐income countries has heightened concerns about limited resources and barriers to care. This challenge is particularly urgent in Sub‐Saharan Africa (SSA), where cancer rates are rising sharply. Here, data from population‐based cancer registries in nine SSA countries was assessed to
Tamara König   +19 more
wiley   +1 more source

Stakeholder perception of quality management of investigator-initiated clinical trials. [PDF]

open access: yesBMC Med Ethics
Li W   +7 more
europepmc   +1 more source

Cancer detection using human papillomavirus self‐sampling targeting long‐term non‐attenders in an organized cervical screening program

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The strategy to offer self‐sampling for human papillomavirus testing to increase cervical cancer screening attendance among long‐term non‐attenders has been mostly validated in randomized trials. This real‐life implementation of self‐sampling for long‐term non‐attenders to the routine screening program in the capital region of Sweden ...
K. Miriam Elfström   +3 more
wiley   +1 more source

A systemic methodology for risk management in healthcare sector [PDF]

open access: yes, 2011
Anna Corinna Cagliano   +62 more
core   +1 more source

Home - About - Disclaimer - Privacy